Vasilios Karavasilis

Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression

E. Ioachim, Antonia Charchanti, Evangelos Briasoulis et al. · European Journal of Cancer · 2002 · 302 citations

Fibrosis, Breast Oncology, Medicine +11

Significant clinical benefit of first‐line palliative chemotherapy in advanced soft‐tissue sarcoma

Vasilios Karavasilis, Beatrice Seddon, S. Ashley et al. · Cancer · 2008 · 205 citations · Full text

Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)

L. Rhoda Molife, Gerhardt Attard, Peter C.C. Fong et al. · Annals of Oncology · 2009 · 181 citations

Urology, Histone Deacetylase Inhibitor, Single-arm Trial +7

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

Daniel P. Petrylak, Ronald de Wit, Kim N. et al. · The Lancet · 2017 · 175 citations · Full text

Platinum-based Therapy, Urology, Metastatic Urothelial Carcinoma +8

Phase I Pharmacokinetic and Pharmacodynamic Study of LAQ824, a Hydroxamate Histone Deacetylase Inhibitor with a Heat Shock Protein-90 Inhibitory Profile, in Patients with Advanced Solid Tumors

Johann S. de Bono, Rebecca Kristeleit, Anthony W. Tolcher et al. · Clinical Cancer Research · 2008 · 116 citations · Full text